XML 18 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders' Equity - Additional Information (Detail) (USD $)
6 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2012
Jun. 30, 2012
1.875% Convertible Notes
Dec. 31, 2011
1.875% Convertible Notes
Jun. 20, 2007
1.875% Convertible Notes
Jun. 30, 2012
2.50% Convertible Notes
Mar. 31, 2012
2.50% Convertible Notes
Dec. 31, 2011
2.50% Convertible Notes
May 23, 2011
2.50% Convertible Notes
Aug. 13, 2009
Stock Incentive Plan 2009
Jun. 30, 2012
Stock Incentive Plan 2009
Jun. 30, 2012
Amended and Restated Stock Incentive Plan 2009
Oct. 27, 2011
Stock Repurchase Program
Jun. 30, 2012
Stock Repurchase Program
Jun. 30, 2012
Stock Repurchase Program
Jun. 30, 2011
Stock Options
Jun. 30, 2012
Restricted Stock
Jun. 30, 2011
Restricted Stock
Jun. 30, 2012
Restricted Stock
Jun. 30, 2011
Restricted Stock
Jun. 30, 2012
Minimum
Jun. 30, 2012
Maximum
Class of Stock [Line Items]                                          
Number of common stock shares authorized under Equity Incentive Plan                 3,000,000   7,000,000                    
Plan expiration date                 Aug. 13, 2019   Aug. 15, 2022                    
Number of additional common stock shares approved for issuance under amended and restated 2009 Equity Incentive Plan                     4,000,000                    
Shareholders annual meeting date                     Aug. 15, 2022                    
Common stock reserved for issuance                   23,947                      
Repurchase of common stock authorized value                       $ 200,000,000                  
Period of common stock repurchase, years                       3 years                  
Repurchase of common stock, shares                         3,207,750 5,237,468              
Repurchase of common stock, value 85,062,000                       50,000,000 85,100,000              
Stock repurchase, remaining available amount                           95,200,000              
Options grant, expected life 7 years                                     5 years 10 years
Debt instrument, interest rate, stated percentage   1.875% 1.875% 1.875% 2.50% 2.50% 2.50% 2.50%                          
Compensation expense related to stock grants                             200,000 2,600,000 2,500,000 5,200,000 4,800,000    
Compensation cost not yet recognized                               12,100,000   12,100,000      
Compensation cost not yet recognized, period for recognition                                   4 years      
Restricted common stock, value of shares withheld                               $ 300,000 $ 400,000 $ 400,000 $ 2,200,000